Maurer K P, Refior H J
Orthopädische Klinik und Poliklinik Klinikum Grosshadern, Ludwig-Maximilians-Universität München.
Z Orthop Ihre Grenzgeb. 1996 Jan-Feb;134(1):21-8. doi: 10.1055/s-2008-1037413.
The aim of this follow-up study was to see if, by the application of a special endoprosthesis for the replacement of the proximal femur, a radical tumour resection could be achieved and/or the function of the lower limb could be preserved or restored respectively. Between 11/1986 and 12/1992 a proximal femoral endoprosthesis was implanted in 9 patients with metastases in the proximal femur. In 21 cases this special endoprosthesis was used in the revision of conventional cemented total hip arthroplasties with loosening of the implant and extreme bone loss at the proximal femur. Twenty-three patients were seen for a follow-up examination with an average follow-up period of 20 months. In all cases the walking ability was preserved or restored respectively. The majority (22/23) of the patients had complete or, nearly complete pain relief. In those patients with skeletal metastases, were no cases of local reoccurrence. The majority problem of this endoprosthesis was the increased risk of dislocation. There is a clear indication for such a special endoprosthesis in the treatment of primary and secondary bone tumours in the proximal femur. For revision of cemented total hip prostheses with loosening and bony defects a revision prosthesis with uncemented distal fixation should be used.